Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Jonathan David Lanoy | SVP Chief Accounting Officer | 2025-08-13 | 5,000 | $16.51 | $82.55kSell |
Nathan G. Brower | EVP General Counsel | 2025-08-13 | 9,996 | $16.54 | $165.33kSell |
Jonathan David Lanoy | SVP Chief Accounting Officer | 2025-07-21 | 341 | $14.80 | $5.05kSell |
Bryant J. Yates | EVP President Europe | 2025-07-21 | 1,738 | $14.80 | $25.72kSell |
Nathan G. Brower | EVP General Counsel | 2025-07-21 | 1,491 | $14.80 | $22.07kSell |
Tracee Comstock | VP Human Resources | 2025-07-21 | 1,235 | $14.80 | $18.28kSell |
Daniel C. Norman | EVP President Asia | 2025-07-21 | 1,703 | $14.80 | $25.20kSell |
Terrence Moorehead | Chief Executive Officer | 2025-07-21 | 9,302 | $14.80 | $137.67kSell |
Martin A. Gonzalez | EVP Global Supply Chain | 2025-07-21 | 3,781 | $14.80 | $55.96kSell |
Shanghai Fosun Pharmaceutical Group Co Ltd | 10% Owner | 2025-06-27 | 2,854,607 | $11.46 | $32.71MSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Willem Mesdag | 99.13% | 17,481,976 | $295.01M | Insider |
Eugene L. Hughes | 29.40% | 5,184,268 | $87.48M | Insider |
Pauline Hughes | 28.16% | 4,966,513 | $83.81M | Insider |
Jeffrey D. Watkins | 21.41% | 3,775,681 | $63.71M | Insider |
Delta Partners LP | 18.02% | 3,178,004 | $53.63M | Insider |
Shanghai Fosun Pharmaceutical Group Co Ltd | 16.55% | 2,918,774 | $49.25M | Insider |
Wynnefield Partners Small Cap Value LP | 16.46% | 2,902,245 | $48.98M | Insider |
Fosun Pharma Usa Inc | 16.19% | 2,854,607 | $48.17M | Insider |
Wynnefield Capital Inc | 14.03% | 2,473,686 | $41.74M | Institution |
Kristine F. Hughes | 10.92% | 1,925,963 | $32.50M | Insider |